Literature DB >> 22460831

Glucose reintroduction triggers the activation of Nrf2 during experimental ischemia reperfusion.

Daniel Crean1, Luca Felice, Cormac T Taylor, Hamid Rabb, Paul Jennings, Martin O Leonard.   

Abstract

Reperfusion results in a rapid reintroduction of oxygen, glucose, and other restricted components to an ischemic tissue. It brings with it not only the necessary components for cell survival but also a burst of oxidative stress and cellular damage. In this study, our primary aims were to investigate glucose as a determining factor for the activation of the transcription factor NF-E2-related factor 2 (Nrf2) upon reperfusion and the expression of downstream anti-oxidant NADPH-dependent reductases. Exposure of renal epithelial HK-2 cells to oxygen and glucose reintroduction after depletion resulted in an increase in nuclear translocation of Nrf2 protein in a manner dependent upon glucose. This activation and the induction of the Nrf2-dependent gene NAD(P)H dehydrogenase, quinone 1 (NQO1) was observed to be maximum at a concentration of 5 mM glucose. Microarray analysis of mRNA from siRNA targeted cells under these conditions revealed the Nrf2-dependent expression of NADPH-dependent reductase enzymes NQO1, Aldo-keto reductase family 1, members C1-3 and dehydrogenase/reductase (SDR family) member 2 (DHRS2), all genes demonstrated to protect against oxidative stress-mediated cellular injury. In addition, NQO1 and DHRS2 mRNA levels were specifically upregulated on glucose reintroduction and were also increased in an in vivo ischemia reperfusion injury model of murine renal pedicle clamping. In conclusion, we demonstrate that glucose reintroduction after depletion activates Nrf2 and Nrf2 regulated NADPH-dependent reductase expression. We suggest these findings represent a previously unreported mechanism for the activation of Nrf2 as a cytoprotective pathway in IRI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460831     DOI: 10.1007/s11010-012-1300-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin.

Authors:  Guoxiang Shen; Changjiang Xu; Rong Hu; Mohit R Jain; Avantika Gopalkrishnan; Sujit Nair; Mou-Tuan Huang; Jefferson Y Chan; Ah-Ng Tony Kong
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

2.  Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans.

Authors:  Stavros P Loukogeorgakis; Merlijn J van den Berg; Reecha Sofat; Dorothea Nitsch; Marietta Charakida; Bu'Hussein Haiyee; Eric de Groot; Raymond J MacAllister; Taco W Kuijpers; John E Deanfield
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

3.  Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue.

Authors:  N Shafqat; J Shafqat; G Eissner; H-U Marschall; K Tryggvason; U Eriksson; F Gabrielli; H Lardy; H Jörnvall; U Oppermann
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

4.  15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.

Authors:  Martin O Leonard; Kieran Hannan; Melissa J Burne; David W P Lappin; Peter Doran; Patrick Coleman; Catherine Stenson; Cormac T Taylor; Frank Daniels; Catherine Godson; Nicos A Petasis; Hamid Rabb; Hugh R Brady
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

5.  Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.

Authors:  R Venugopal; A K Jaiswal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion.

Authors:  Qun Chen; Shadi Moghaddas; Charles L Hoppel; Edward J Lesnefsky
Journal:  J Pharmacol Exp Ther       Date:  2006-09-21       Impact factor: 4.030

7.  NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.

Authors:  Magali Balteau; Nicolas Tajeddine; Carole de Meester; Audrey Ginion; Christine Des Rosiers; Nathan R Brady; Caroline Sommereyns; Sandrine Horman; Jean-Louis Vanoverschelde; Philippe Gailly; Louis Hue; Luc Bertrand; Christophe Beauloye
Journal:  Cardiovasc Res       Date:  2011-08-22       Impact factor: 10.787

Review 8.  Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.

Authors:  Ling Gao; Giovanni E Mann
Journal:  Cardiovasc Res       Date:  2009-01-29       Impact factor: 10.787

9.  Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.

Authors:  Marta Monge; Eva Colas; Andreas Doll; Antonio Gil-Moreno; Josep Castellvi; Berta Diaz; Marta Gonzalez; Rafael Lopez-Lopez; Jordi Xercavins; Ramon Carreras; Francesc Alameda; Francesc Canals; Franco Gabrielli; Jaume Reventos; Miguel Abal
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

10.  Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung.

Authors:  Martin O Leonard; Katherine Howell; Stephen F Madden; Christine M Costello; Desmond G Higgins; Cormac T Taylor; Paul McLoughlin
Journal:  Am J Respir Crit Care Med       Date:  2008-08-08       Impact factor: 21.405

View more
  5 in total

1.  Bronchial epithelial innate and adaptive immunity signals are induced by polycyclic aromatic hydrocarbons.

Authors:  Kirsty Meldrum; Timothy W Gant; Sameirah Macchiarulo; Martin O Leonard
Journal:  Toxicol Res (Camb)       Date:  2016-02-09       Impact factor: 3.524

2.  Nrf2 Regulates β-Cell Mass by Suppressing β-Cell Death and Promoting β-Cell Proliferation.

Authors:  Sharon Baumel-Alterzon; Liora S Katz; Gabriel Brill; Clairete Jean-Pierre; Yansui Li; Isabelle Tse; Shyam Biswal; Adolfo Garcia-Ocaña; Donald K Scott
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

Review 3.  A review of the evidence that ochratoxin A is an Nrf2 inhibitor: implications for nephrotoxicity and renal carcinogenicity.

Authors:  Alice Limonciel; Paul Jennings
Journal:  Toxins (Basel)       Date:  2014-01-20       Impact factor: 4.546

4.  Systems biology modeling of omics data: effect of cyclosporine a on the Nrf2 pathway in human renal cells.

Authors:  Jérémy Hamon; Paul Jennings; Frederic Y Bois
Journal:  BMC Syst Biol       Date:  2014-06-25

5.  DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.

Authors:  Y Zhou; L Wang; X Ban; T Zeng; Y Zhu; M Li; X-Y Guan; Y Li
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.